50528EGP
- Active ingredient
- enzalutamide
- Strength
- 40mg
- Form
- tablet
- Manufacturer
- astellas pharma inc > multipharma
- Route
- oral.solid
Uses
Used for treatment of castration-resistant and castration-sensitive prostate cancer in appropriate patients.
Do not use if
No specific contraindications are listed, except hypersensitivity to formulation components.
Side effects
Fatigue, hypertension, falls, fractures, hot flushes, and headache may occur.
Warnings
Monitor for seizures, cardiovascular events, falls, fractures, and neurologic symptoms.
How it works
Androgen receptor inhibitor that blocks androgen signaling in prostate cancer cells.
Storage
Store at room temperature in the original package.
